JIM
MED icon

Jupiter Investment Management’s Medifast MED Stock Holding History

Jupiter Investment Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-37,020
Closed -$3.84M – 485
2019
Q3 		$3.84M Sell
37,020
-167,509
-82% -$18M 0.05% 261
2019
Q2 		$26.2M Sell
204,529
-110,483
-35% -$15.3M 0.27% 99
2019
Q1 		$40.2M Buy
315,012
+11,347
+4% +$1.44M 0.37% 83
2018
Q4 		$38M Buy
303,665
+158,624
+109% +$27.1M 0.34% 85
2018
Q3 		$32.1M Buy
145,041
+13,201
+10% +$2.68M 0.22% 109
2018
Q2 		$21.1M Hold
131,840
– – 0.15% 129
2018
Q1 		$12.3M Buy
131,840
+22,971
+21% +$1.72M 0.1% 138
2017
Q4 		$7.6M Buy
108,869
+92,244
+555% +$6.12M 0.07% 163
2017
Q3 		$987K Buy
16,625
+12,588
+312% +$626K 0.01% 227
2017
Q2 		$167K Hold
4,037
– – ﹤0.01% 352
2017
Q1 		$179K Buy
+4,037
New +$174K ﹤0.01% 341

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jupiter Investment Management's MED Position: Q4 2019 in Review

Jupiter Investment Management sold out of Medifast (MED) in Q4 2019, closing a stake of 37,020 shares — an estimated $3.84M sold.

Jupiter Investment Management first reported a position in MED in Q1 2017 and held it in 11 quarters. The position peaked at $40.2M in Q1 2019. 219 funds tracked by Wall St. Rank hold MED as of Q4 2019.

  • Jupiter Investment Management reported no remaining Medifast position as of Q4 2019 after selling out during the quarter.
  • Jupiter Investment Management sold 37,020 Medifast shares in Q4 2019, an estimated $3.84M.
  • Jupiter Investment Management first reported a position in Medifast in Q1 2017 and held it in 11 quarters.
  • Jupiter Investment Management's Medifast position peaked at $40.2M in Q1 2019.
  • 219 funds tracked by Wall St. Rank held Medifast as of Q4 2019.

Based on Jupiter Investment Management's 13F filing for Q4 2019, filed 3 Feb 2020.